and HKL Suspension Ameliorate DSS-induced Ulcerative Colitis in Mice by Improving the Intestinal Barrier Inhibiting the NLRP3 Inflammasome and Pathogenic Bacteria

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Jul 19

PMID 39027449

Authors

Jiwei Zhu

Hanming Wang

Muaitaer Aisikaer

Zainaipuguli Yisimayili

Tongtong Yang

Wenjun Zhou

Jianfeng Zhao

Kurexi Yunusi

Kasimujiang Aximujiang

Affiliations

Soon will be listed here.

Abstract

Ulcerative Colitis(UC) is a chronic intestinal inflammation affecting the intestines, yet its underlying causes remain unclear. In recent decades, the global prevalence of UC has been on the rise, leading to an increasing demand for therapeutic drugs with minimal side effects. Huan Kui Le (HKL), a traditional Chinese medicine compound, has demonstrated promising efficacy when combined with for UC intervention. However, the precise therapeutic mechanism of this combination remains unknown. The study focused on understanding the mechanisms of UC by examining the effects of Lac. and HKL (LH) treatment. The outcomes discovered that the disruption of gut microbiota, triggered by the activation of the NLRP3 inflammasome, plays a crucial role in UC development. This disruption exacerbates UC symptoms by causing disturbances in inflammatory cytokines and mucosal permeability. We investigated the dynamic changes following the application of this treatment using 16S rRNA sequencing, HE, WB, IHC, and ELISA. Compared with the UC group, LH treatment reduced colon pathological injury, improved colon length, and decreased IL-1 β serum levels. Furthermore, it restored the expression of TJs and preserved mucosal barrier integrity. LH treatment also mitigated colon injury by attenuating the expression of pyroptosis-related genes and proteins, such as NLRP3 and Caspase-1. Additionally, LH treatment altered the gut microbiota's microecology, characterized by a reduction in pathogenic bacteria abundance like Escherichia-shigella and an increase in beneficial bacteria abundance like Akkermansia and Erysipelatoclostridium. Overall, our findings indicate that LH therapy may be associated with intestinal barrier repair, inflammasome inhibition, and gut microbiota regulation, suggesting its potential as a UC treatment.

References

Zhai Q, Feng S, Arjan N, Chen W . A next generation probiotic, . Crit Rev Food Sci Nutr. 2018; 59(19):3227-3236. DOI: 10.1080/10408398.2018.1517725. View

Rawat M, Nighot M, Al-Sadi R, Gupta Y, Viszwapriya D, Yochum G . IL1B Increases Intestinal Tight Junction Permeability by Up-regulation of MIR200C-3p, Which Degrades Occludin mRNA. Gastroenterology. 2020; 159(4):1375-1389. PMC: 11752806. DOI: 10.1053/j.gastro.2020.06.038. View

Dinh D, Volpe G, Duffalo C, Bhalchandra S, Tai A, Kane A . Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J Infect Dis. 2014; 211(1):19-27. PMC: 4326316. DOI: 10.1093/infdis/jiu409. View

Greten F, Grivennikov S . Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity. 2019; 51(1):27-41. PMC: 6831096. DOI: 10.1016/j.immuni.2019.06.025. View

Ding J, Wang K, Liu W, She Y, Sun Q, Shi J . Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016; 535(7610):111-6. DOI: 10.1038/nature18590. View

Kim J . [Inflammatory bowel diseases and inflammasome]. Korean J Gastroenterol. 2011; 58(6):300-10. DOI: 10.4166/kjg.2011.58.6.300. View

Tornavaca O, Chia M, Dufton N, Osuna Almagro L, Conway D, Randi A . ZO-1 controls endothelial adherens junctions, cell-cell tension, angiogenesis, and barrier formation. J Cell Biol. 2015; 208(6):821-38. PMC: 4362456. DOI: 10.1083/jcb.201404140. View

Tian S, Guo R, Wei S, Kong Y, Wei X, Wang W . Curcumin protects against the intestinal ischemia-reperfusion injury: involvement of the tight junction protein ZO-1 and TNF-α related mechanism. Korean J Physiol Pharmacol. 2016; 20(2):147-52. PMC: 4770104. DOI: 10.4196/kjpp.2016.20.2.147. View

Schultz M, Sartor R . Probiotics and inflammatory bowel diseases. Am J Gastroenterol. 2000; 95(1 Suppl):S19-21. DOI: 10.1016/s0002-9270(99)00812-6. View

10.

Maria-Ferreira D, Nascimento A, Cipriani T, Santana-Filho A, Watanabe P, Sant Ana D . Rhamnogalacturonan, a chemically-defined polysaccharide, improves intestinal barrier function in DSS-induced colitis in mice and human Caco-2 cells. Sci Rep. 2018; 8(1):12261. PMC: 6095889. DOI: 10.1038/s41598-018-30526-2. View

11.

Liu J, Wang J, Zhou Y, Han H, Liu W, Li D . Integrated omics analysis reveals differences in gut microbiota and gut-host metabolite profiles between obese and lean chickens. Poult Sci. 2022; 101(11):102165. PMC: 9523386. DOI: 10.1016/j.psj.2022.102165. View

12.

Buscarinu M, Fornasiero A, Romano S, Ferraldeschi M, Mechelli R, Renie R . The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology. Front Immunol. 2019; 10:1916. PMC: 6724505. DOI: 10.3389/fimmu.2019.01916. View

13.

Chang Z, Liu H, Leu Y, Hsu C, Lee T . Modulation of Gut Microbiota Combined with Upregulation of Intestinal Tight Junction Explains Anti-Inflammatory Effect of Corylin on Colitis-Associated Cancer in Mice. Int J Mol Sci. 2022; 23(5). PMC: 8910903. DOI: 10.3390/ijms23052667. View

14.

Bauer C, Duewell P, Mayer C, Lehr H, Fitzgerald K, Dauer M . Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut. 2010; 59(9):1192-9. DOI: 10.1136/gut.2009.197822. View

15.

Du X, Chen W, Wang Y, Chen C, Guo L, Ju R . Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation. Int Immunopharmacol. 2017; 45:16-25. DOI: 10.1016/j.intimp.2017.01.015. View

16.

Mai C, Wu M, Wang C, Su Z, Cheng Y, Zhang X . Palmatine attenuated dextran sulfate sodium (DSS)-induced colitis via promoting mitophagy-mediated NLRP3 inflammasome inactivation. Mol Immunol. 2018; 105:76-85. DOI: 10.1016/j.molimm.2018.10.015. View

17.

Ungaro R, Mehandru S, Allen P, Peyrin-Biroulet L, Colombel J . Ulcerative colitis. Lancet. 2016; 389(10080):1756-1770. PMC: 6487890. DOI: 10.1016/S0140-6736(16)32126-2. View

18.

Holzhausen E, Malecki K, Sethi A, Gangnon R, Cadmus-Bertram L, Deblois C . Assessing the relationship between physical activity and the gut microbiome in a large, population-based sample of Wisconsin adults. PLoS One. 2022; 17(10):e0276684. PMC: 9605031. DOI: 10.1371/journal.pone.0276684. View

19.

Filardy A, He J, Bennink J, Yewdell J, Kelsall B . Posttranscriptional control of NLRP3 inflammasome activation in colonic macrophages. Mucosal Immunol. 2015; 9(4):850-8. PMC: 4889550. DOI: 10.1038/mi.2015.109. View

20.

Shen L, Weber C, Raleigh D, Yu D, Turner J . Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol. 2010; 73:283-309. PMC: 4655434. DOI: 10.1146/annurev-physiol-012110-142150. View